Glaxosmithkline Intellectual Property Development Limited

Hamilton D Dickson

Pek Yoke Chong

Martha Alicia De La Rosa

Wieslaw Mieczyslaw Kazmierski

Vicente Samano

Vincent Wing-Fai Tai

Jason Gordon Weatherhead

John G Catalano

Martin R Leivers

Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.

5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.

Modulators of indoleamine 2,3-dioxygenase

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression. 

Growing community of inventors

Research Triangle Park, NC, United States of America

Hamilton D Dickson